​

Outlook Therapeutics Ownership | Who Owns Outlook Therapeutics?

OverviewForecastFinancialsChartTranscripts

Outlook Therapeutics Ownership Summary

Outlook Therapeutics is owned by 22.95% institutional investors, 35.39% insiders, and 41.66% retail investors. Woodline partners lp is the largest institutional shareholder, holding 0% of OTLK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.38% of its assets in Outlook Therapeutics shares.

OTLK Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOutlook Therapeutics22.95%35.39%41.66%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Woodline partners lp---
Gsa capital partners llp---
Cwm---
Ifp advisors---
Advisor group---
Jane street group---
Armstrong advisory group---
Rosalind advisors---
Xtx topco---
Qube research---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Woodline partners lp---
Gsa capital partners llp---
Cwm---
Ifp advisors---
Advisor group---
Jane street group---
Armstrong advisory group---
Rosalind advisors---
Xtx topco---
Qube research---

Top Buyers

HolderShares% AssetsChange
Ifp advisors---3.00
Cwm---283.00
Federated hermes---477.00
Advisor group---3.38K
Armstrong advisory group---3.58K

Top Sellers

HolderShares% AssetsChange
Rosalind advisors---450.00K
Woodline partners lp---151.51K
Gsa capital partners llp---100.32K
Jane street group---26.22K
Qube research---13.51K

Sold Out

HolderChange
Ifp advisors-3.00
Cwm-283.00
Federated hermes-477.00
Advisor group-3.38K
Armstrong advisory group-3.58K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025633.28%7,084,42564.93%227.30%388.57%138.33%
Dec 31, 202461-12.86%4,295,401-48.73%170.87%35-12.50%1220.00%
Sep 30, 20241-450,000-119.48%--100.00%--
Jun 30, 20241-66.67%450,00042.57%353.60%1---100.00%
Mar 31, 20243-96.43%315,638-98.93%21.88%1-97.62%1-92.86%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF442.51K1.38%-
Vanguard Total Stock Mkt Idx Inv442.51K1.34%-
iShares Russell 2000 ETF523.16K1.22%255.00
Vanguard Institutional Extnd Mkt Idx Tr281.28K0.85%-
Fidelity Small Cap Index167.42K0.52%12.41K
CREF Stock R1100.34K0.42%65.13K
Fidelity Extended Market Index127.94K0.40%48.58K
Federated Hermes MDT SCG Institutional88.30K0.37%88.30K
Federated Hermes MDT Small Cap Growth IS88.30K0.37%88.30K
iShares Russell 2000 Growth ETF100.74K0.24%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 26, 2024KENYON LAWRENCE A Chief Financial OfficerBuy$28.45K
Apr 15, 2024Syntone Ventures LLC-Buy$8.25M
Apr 15, 2024Syntone Ventures LLC-Buy$5.00M
Mar 28, 2024Haddadin Yezan Munther-Buy$22.24K
Mar 07, 2024Evanson Jeff CHIEF COMMERCIAL OFFICERBuy$26.24K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q31-
2024 Q22-

OTLK Ownership FAQ

Who Owns Outlook Therapeutics?

Outlook Therapeutics shareholders are primarily institutional investors at 22.95%, followed by 35.39% insiders and 41.66% retail investors. The average institutional ownership in Outlook Therapeutics's industry, Biotech Stocks , is 63.96%, which Outlook Therapeutics falls below.

Who owns the most shares of Outlook Therapeutics?

Outlook Therapeutics’s largest shareholders are Woodline partners lp (0 shares, 0%), Gsa capital partners llp (0 shares, 0%), and Cwm (0 shares, 0%). Together, they hold 0% of Outlook Therapeutics’s total shares outstanding.

Does Blackrock own Outlook Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Outlook Therapeutics.

Who is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested?

Woodline partners lp is Outlook Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Outlook Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Outlook Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Outlook Therapeutics shares, with 1.38% of its total shares outstanding invested in 442.51K Outlook Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools